JP:2395 Stock Latest News
Company AnnouncementsShin Nippon Biomedical Laboratories Announces ¥20 Interim Dividend1w ago2395
Company AnnouncementsShin Nippon Biomedical Laboratories Presents First-Half Financial Results Briefing1w ago2395
Company AnnouncementsSNBL Reports Six-Month Revenue Growth and Higher Attributable Profit1w ago2395
Company AnnouncementsSNBL Corrects Earnings Per Share Figure in Q1 FY2026 Disclosure3M ago2395
Company AnnouncementsShin Nippon Biomedical Laboratories Lifts First-Half Earnings Forecast on Strong CRO Performance3M ago2395
Company AnnouncementsSNBL Sets New Management Structure and Highlights FY3/27 Q1 CRO Strategy3M ago2395Company AnnouncementsShin Nippon Biomedical Laboratories Keeps Annual Dividend at ¥50 as CRO Business Hits Record Highs5M ago2395
Company AnnouncementsSNBL backs U.S. launch build-out for migraine drug Atzumi after licensing talks stall6M ago2395
Company AnnouncementsShin Nippon Biomedical Laboratories Outlines FY2026 Results and Strategic Focus6M ago2395
Company AnnouncementsSNBL Posts Flat Revenue, Lower Profits but Stronger Balance Sheet and Cash Ahead of FY2027 Growth Push6M ago2395
Company AnnouncementsSNBL to Shift Meeting Leadership to Board Chair in Governance Revamp6M ago2395
Company AnnouncementsSNBL Revamps Top Management to Drive Long-Term Growth6M ago2395Company AnnouncementsSNBL Cuts Full-Year Revenue and Operating Profit Outlook but Nudges Net Income Forecast Higher9M ago2395
Company AnnouncementsSNBL Warns of Added Costs as U.S. Migraine Drug Unit Talks Continue10M ago2395
Company AnnouncementsShin Nippon Biomedical Announces Interim Dividends1y ago2395
Company AnnouncementsShin Nippon Biomedical Laboratories Exceeds Financial Forecasts for H1 20251y ago2395
Company AnnouncementsShin Nippon Biomedical Laboratories Reports Increased Revenue but Declining Profits1y ago2395Company AnnouncementsShin Nippon Biomedical Laboratories Reports Mixed Financial Results for Q1 20251y ago2395



